Rezolute, Inc.

Public companies file this within four business days when something important happens that investors should know about before the next quarterly report.

Rezolute, Inc. filed this to release information to investors under Regulation FD — usually a press release, conference presentation, or other event the company considers important. 1 Rezolute Announces Positive Interim Data for its Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism Study now 50% enrolled 6 of 8 participants have already met the responder criterion for the study’s primary endpoint Topline results for the fully enrolled open-label study are expected in the second half of 2026 REDWOOD CITY, Calif. (Nasdaq: R…